Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P T Francis

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Neuroscience Letters|May 8, 2007
Genetic variation in the 5-HT2A receptor and altered neocortical [3H] ketanserin binding in Alzheimer's diseaseC Holmes, M McCulley, J A R Nicoll, et al.
Brain Research|June 30, 1987
Catecholaminergic neurones assessed ante-mortem in Alzheimer's diseaseA M Palmer, P T Francis, D M Bowen, et al.
Brain Research|May 2, 1994
Postmortem brains reveal similar but not identical amyloid precursor protein-like immunoreactivity in Alzheimer compared with other dementiasM T Webster, P T Francis, A W Procter, et al.
Journal of Neurochemistry|March 1, 1988
Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's diseaseA W Procter, A M Palmer, P T Francis, et al.
Psychopharmacology|November 21, 2007
Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapyD M Bowen, A W Procter, D M A Mann, et al.
Journal of Neural Transmission. Supplementum|January 1, 1994
An aspect of Alzheimer neuropathology after suicide transport damageI P Chessell, P T Francis, M T Webster, et al.
Psychopharmacology|November 20, 2004
Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's diseaseM K Lai, S W Tsang, J T Alder, et al.
Journal of Neurochemistry|April 1, 1996
Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medicationC P Chen, J T Alder, D M Bowen, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 18, 2003
[3H]GR113808 binding to serotonin 5-HT(4) receptors in the postmortem neocortex of Alzheimer disease: a clinicopathological studyM K Lai, S W Tsang, P T Francis, et al.
Psychopharmacology|April 1, 2008
Loss of [3H]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosisS W Y Tsang, P T Francis, M M Esiri, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Neuroscience Letters|May 8, 2007
Genetic variation in the 5-HT2A receptor and altered neocortical [3H] ketanserin binding in Alzheimer's diseaseC Holmes, M McCulley, J A R Nicoll, et al.
Brain Research|June 30, 1987
Catecholaminergic neurones assessed ante-mortem in Alzheimer's diseaseA M Palmer, P T Francis, D M Bowen, et al.
Brain Research|May 2, 1994
Postmortem brains reveal similar but not identical amyloid precursor protein-like immunoreactivity in Alzheimer compared with other dementiasM T Webster, P T Francis, A W Procter, et al.
Journal of Neurochemistry|March 1, 1988
Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's diseaseA W Procter, A M Palmer, P T Francis, et al.
Psychopharmacology|November 21, 2007
Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapyD M Bowen, A W Procter, D M A Mann, et al.
Journal of Neural Transmission. Supplementum|January 1, 1994
An aspect of Alzheimer neuropathology after suicide transport damageI P Chessell, P T Francis, M T Webster, et al.
Psychopharmacology|November 20, 2004
Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's diseaseM K Lai, S W Tsang, J T Alder, et al.
Journal of Neurochemistry|April 1, 1996
Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medicationC P Chen, J T Alder, D M Bowen, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 18, 2003
[3H]GR113808 binding to serotonin 5-HT(4) receptors in the postmortem neocortex of Alzheimer disease: a clinicopathological studyM K Lai, S W Tsang, P T Francis, et al.
Psychopharmacology|April 1, 2008
Loss of [3H]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosisS W Y Tsang, P T Francis, M M Esiri, et al.
Pageof 8